Profs Ravi Acharya and Edward Sturrock review the historical foundation, present landscape and future clinical promise of ACE inhibition.

New guidelines were issued by the American Heart Association and American College of Cardiology on Aug. 14. These guidelines ...

IN CHILDREN. AND THAT NUMBER IS EXPECTED TO RISE. SHE WAS COUGHING. SHE COULDN’T CATCH HER BREATH. FOR THE HOLLAND FAMILY OF MANCHESTER. WHAT STARTED AS A COUGH QUICKLY BECAME A FRIGHTENING EXPERIENCE ...

Whopping cough vaccine rates are at their lowest in the UK in 15 years. (Getty Images) A baby has died from whooping cough in the UK amid warnings that vaccination rates among children and pregnant ...

A baby whose mother was not vaccinated against whooping cough died of the disease this year, public health data shows. The infant, who is believed to have been under the age of one, died between March ...

Americans like simple answers. Is something healthy or harmful? We want medicine to be beneficial and not cause side effects. Unfortunately, what works well for one person could be poison for someone ...

Too much potassium in your diet may increase lisinopril-related hyperkalemia. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure and heart failure and to ...

CHRIS, THANK YOU. DATA FROM THE SOUTH CAROLINA DEPARTMENT OF HEALTH SHOWS THAT MORE THAN A THIRD OF REPORTED WHOOPING COUGH CASES CAN BE FOUND IN GREENVILLE AND SPARTANBURG COUNTIES. AND TODAY, ...

Pertussis infections have surged in recent months, and some people may need an additional shot for protection. By Teddy Rosenbluth After a brief lull during the pandemic, whooping cough has bounced ...

Two Kentucky infants died from whooping cough in the past six months, the first such deaths since 2018. Neither infant nor their mothers received the recommended pertussis vaccinations. Kentucky has ...

LOUISVILLE, Ky. (WDRB) — Two infants in Kentucky have died from whooping cough in the last six months. State health officials confirmed the deaths Friday and said neither the infants or their mothers ...

Cough-focused biotech Seyltx has secured the option to license a portfolio of eight GluN2B antagonists from NeurOp, including one candidate that has completed a phase 1 trial. The drugs are all ...